相关实验视频

Updated: Jan 10, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

在NAc D2-MSN中增加GSK3β的活性有助于甲基胺诱导的有条件位置偏好

Jincen Liu¹, Yue Feng¹, Yudian Ye¹

¹NHC Key Laboratory of Forensic Science, College of Forensic Medicine, Xi'an Jiaotong University, Xi'an, China; Bio-evidence Sciences Academy, Western China Science and Technology, Innovation Harbor, Xi'an Jiaotong University, Xi'an, China.

Neuropharmacology

|November 24, 2025

概括

在核 accumbens 中的糖原合成酶激酶3β (GSK3β) 影响甲基胺成. 在获取过程中抑制GSK3β特别减少了与药物相关的行为,突出了D2-MSNs.

科学领域:

神经科学是一个神经科学.
神经药理学神经药理学
成研究研究成研究

背景情况:

葡萄糖200-300个字. 在这里. 糖原合成酶激酶3β (GSK3β) 参与了药物成.
它在甲基胺 (METH) 诱导的有条件位置偏好 (CPP) 中的确切功能尚未完全理解,特别是在关键阶段和特定的神经元亚型方面.

研究的目的:

为了研究GSK3β在METH诱导的CPP期间在核 (NAc) 中的相位特异性作用.
确定涉及METH诱导的CPP的特定中等棘状神经元 (MSN) 亚型.
探索GSK3β抑制对D1和D2MSN活动的影响.

主要方法:

在CPP范式的不同阶段 (获取,巩固,表达) 系统地和通过微注射到NAc中服用GSK3β抑制剂.
使用体内纤维光度成像来监测D1和D2MSN活动.
在NAc D2-MSNs中进行了GSK3β的选择性淘汰.

主要成果:

由METH诱导的CPP与NAc中增强的GSK3β活性有关.
系统性GSK3β抑制降低了所有阶段的METH-CPP.
在获取阶段内NAcGSK3β抑制显著减弱了METH-CPP.
主要在NAc D2-MSN中观察到GSK3β活性升高,而不是D1-MSN.
在NAc D2-MSN中选择性淘汰GSK3β通过重新激活D2-MSN和抑制D1-MSN活性来降低METH-CPP.

结论:

在METH诱导的CPP期间,GSK3β在NAc中发挥着关键的,相位依赖的作用.
获取阶段的GSK3β活动对于建立METH相关记忆至关重要.
这项研究强调了GSK3β对细胞类型的特定作用,D2-MSN特别参与METH奖励处理.
这些发现表明,针对D2-MSN中的GSK3β可能是对甲基胺成的潜在治疗策略.

关键词:

有条件的地方偏好.糖原合成酶激酶3βββ3ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ 中等的脊状神经元.甲基胺是一种甲基胺.核积累的中心 (nucleus accumbens).

更多相关视频

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Published on: February 18, 2016

相关概念视频

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...